Mesalamine - NDC Database (Page 3)
89 records found
Page:
50742-371 Sep 23, 2024
Mesalamine .375 g/1 Oral Capsule, Extended Release by Ingenus Pharmaceuticals, LLC
Mesalamine .375 g/1 Oral Capsule, Extended Release by Ingenus Pharmaceuticals, LLC
51407-274 Jan 25, 2019
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Golden State Medical Supply, Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Golden State Medical Supply, Inc.
51407-900 Jun 05, 2017
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Golden State Medical Supply, Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Golden State Medical Supply, Inc.
51407-976 Jun 06, 2023
Mesalamine .375 g/1 Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
Mesalamine .375 g/1 Oral Capsule, Extended Release by Golden State Medical Supply, Inc.
54092-100 Aug 29, 2017
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Shire Us Manufacturing Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Shire Us Manufacturing Inc.
59651-397 Mar 31, 2023
Mesalamine .375 g/1 Oral Capsule, Extended Release by Aurobindo Pharma Limited
Mesalamine .375 g/1 Oral Capsule, Extended Release by Aurobindo Pharma Limited
60687-650 Sep 06, 2022
Mesalamine .375 g/1 Oral Capsule, Extended Release by American Health Packaging
Mesalamine .375 g/1 Oral Capsule, Extended Release by American Health Packaging
60687-703 Jan 20, 2023
Mesalamine 500 mg Oral Capsule, Extended Release by American Health Packaging
Mesalamine 500 mg Oral Capsule, Extended Release by American Health Packaging
62332-724 Nov 03, 2022
Mesalamine .375 g/1 Oral Capsule, Extended Release by Alembic Pharmaceuticals Inc.
Mesalamine .375 g/1 Oral Capsule, Extended Release by Alembic Pharmaceuticals Inc.
63304-089 May 13, 2022
Mesalamine 500 mg Oral Capsule, Extended Release by Sun Pharmaceutical Industries Inc.
Mesalamine 500 mg Oral Capsule, Extended Release by Sun Pharmaceutical Industries Inc.
63304-175 Feb 01, 2019
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Sun Pharmaceutical Industries, Inc.
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Sun Pharmaceutical Industries, Inc.
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.